AC Immune (ACIU) EBITDA Margin (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | AC Immune | 325.88 Mn | 211.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 293,704.00 |
| Dec 31, 2025 | -253,696.00 |
| Sep 30, 2025 | -23,709.00 |
| Jun 30, 2025 | 47,203.00 |
| Mar 31, 2025 | -31,910.00 |
| Dec 31, 2024 | -166,599.00 |
| Sep 30, 2024 | 307,961.00 |
| Dec 31, 2020 | -38,744.00 |
| Sep 30, 2020 | -22,606.00 |
| Jun 30, 2020 | -138,902.00 |
| Mar 31, 2020 | 212,926.00 |
| Dec 31, 2019 | -300,586.00 |
| Sep 30, 2019 | 179,490.00 |
| Jun 30, 2019 | -105,793.00 |
| Mar 31, 2019 | 137,258.00 |
| Dec 31, 2018 | -76,439.00 |
| Sep 30, 2018 | 4,249.00 |
| Jun 30, 2018 | 20,603.00 |
| Mar 31, 2018 | -86,238.00 |
| Dec 31, 2017 | 176,464.00 |
| Sep 30, 2017 | -34,155.00 |
| Jun 30, 2017 | -94,672.00 |
| Mar 31, 2017 | -128,762.00 |
| Dec 31, 2016 | 151,832.00 |
| Mar 31, 2016 | -19,476.00 |
| Dec 31, 2015 | -107,222.00 |